The US Centers for Disease Control and Prevention and the Food and Medication Administration participated in a World Health Organization meeting to discuss the compositions of the flu vaccine, the UN officer said on Friday.
President Donald Trump has started a 12-month withdrawal procedure for the US to leave WHO on the first day on duty in January, and has since been overseen by the dismantling of the American side of assistance that hit health programs around the world.
“We hope that the break in the business we do with the US is temporary and we hope that we will be able to continue this in full strength in the coming weeks,” said Maria Van Kerkhova, director of the Epidemic Department and Pandemia readiness and prevention of WHO.
“There is information coming out of the US Ministry of Agriculture on the animal side, so I want to be very clear that now they are still contributing,” Kerkhova said.
The comments arrived aside the events, announcing his recommendations for the composition of the flu vaccine for 2025-2026. In the northern hemisphere.
The global health body recommended that vaccines include updated H3N2 strains, mirroring the composition advised for the southern hemisphere.
He also recommended that the zoonotic vaccines include two additional strain of the bird flu, partly in response to the case of the human case detected last year in Australia.
The new report of three doctors says that a persistent post-infective cough will be experienced by so many Canadians this winter will most often be resolved over time.
Despite their wider withdrawal from WHO, they have not moved now to give up Pan American Health Organization (Paho), specialized health agencies for America and the WHO regional office for America.
However, disorders have been reported at regulatory meetings related to the US vaccine after Robert F. Kennedy Jr. assumed the post of head of the Department of Health and Human Services earlier this month.
